Skip to the page

Data / Form D filings / Twister Biotech, Inc.

Twister Biotech, Inc.: Form D filings

Twister Biotech, Inc., a biotechnology company in Houston, TX, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on August 28, 2023, reports $500,000 sold of a $2 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4108 LILLIAN ST., UNIT B, Houston, TX, 77007
Phone
(832) 236-1326
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1716382

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 28, 2023New notice$2,000,000$500,000$1,500,0002Aug 25, 2023sec.gov
Jan 11, 2021New notice$3,000,000$1,115,305$1,884,6952Dec 23, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Evan DaviesDirector
Michael PaviaDirector
Christopher CokerExecutive Officer, Director
Alex StevenExecutive Officer, Director

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Aug 28, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Twister Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.